Powered by ClinicalTrials.gov
18 trials
0
ExcellentPhase 3Recruiting
STELLAR-3: Semaglutide vs. Placebo in Type 2 Diabetes with Chronic Kidney Disease
Type 2 Diabetes MellitusChronic Kidney Disease
Novo Nordisk|Baltimore, MD
342/500 enrolled
Updated 2 weeks ago
0
ExcellentPhase 3Recruiting
RENAL-PROTECT: Finerenone in Diabetic Kidney Disease with Hypertension
Type 2 Diabetes MellitusChronic Kidney DiseaseHypertension
Bayer|Washington, DC
412/800 enrolled
Updated 2 weeks ago
0
ExcellentPhase 4Recruiting
CARDIO-RENAL: Dapagliflozin Outcomes in CKD with Cardiovascular Risk
Chronic Kidney DiseaseType 2 Diabetes MellitusCardiovascular Disease
AstraZeneca|Durham, NC
756/1200 enrolled
Updated 3 weeks ago
0
ExcellentPhase 1/2Recruiting
INSULIN-NEXT: Oral Insulin Analog OI-338GT in Type 2 Diabetes
Type 2 Diabetes Mellitus
Novo Nordisk|Philadelphia, PA
45/120 enrolled
Updated 2 weeks ago
0
ExcellentPhase 2Recruiting
HARMONY-DM: Tirzepatide for Glycemic and Lipid Control in T2DM with Dyslipidemia
Type 2 Diabetes MellitusHyperlipidemia
Eli Lilly|Boston, MA
178/300 enrolled
Updated 2 weeks ago
0
FairPhase 3Recruiting
RISE-BC: Ribociclib + Endocrine Therapy in HR+/HER2- Early Breast Cancer
Breast CancerHR-positive Breast Cancer
Novartis|Boston, MA
234/600 enrolled
Updated 1 months ago
0
FairPhase 3Recruiting
REDEFINE-OBESITY: Orforglipron Oral GLP-1 for Chronic Weight Management
ObesityOverweight
Eli Lilly|Chicago, IL
678/1500 enrolled
Updated 2 weeks ago
0
FairPhase 2Recruiting
BEACON-LUNG: Pembrolizumab + Novel ADC in Advanced NSCLC
Non-Small Cell Lung CancerNSCLC
Merck|Houston, TX
112/250 enrolled
Updated 3 weeks ago
0
FairPhase 2Recruiting
SPECTRUM-CRC: Tucatinib + Trastuzumab in HER2+ Metastatic Colorectal Cancer
Colorectal CancerHER2-positive Cancer
Seagen (Pfizer)|Rochester, MN
67/150 enrolled
Updated 2 weeks ago
0
FairPhase 3Recruiting
CLARITY-AD2: Lecanemab Maintenance Dosing in Early Alzheimer's Disease
Alzheimer's DiseaseMild Cognitive Impairment
Eisai / Biogen|Boston, MA
198/400 enrolled
Updated 4 weeks ago
0
FairPhase 2Recruiting
INSPIRE-MDD: Psilocybin-Assisted Therapy for Treatment-Resistant Depression
Major Depressive DisorderTreatment-Resistant Depression
COMPASS Pathways|New York, NY
78/200 enrolled
Updated 2 weeks ago
0
FairPhase 3Recruiting
RHYTHM-AF: Pulsed Field Ablation vs. Radiofrequency in Atrial Fibrillation
Atrial FibrillationParoxysmal Atrial Fibrillation
Boston Scientific|Houston, TX
189/400 enrolled
Updated 3 weeks ago
0
FairPhase 3Recruiting
ADVANCE-CD: Risankizumab Induction and Maintenance in Crohn's Disease
Crohn's DiseaseInflammatory Bowel Disease
AbbVie|Los Angeles, CA
312/500 enrolled
Updated 3 weeks ago
0
FairPhase 1/2Recruiting
MOTION-PD: Gene Therapy for Parkinson's Disease Motor Symptoms
Parkinson's Disease
Voyager Therapeutics|San Francisco, CA
12/40 enrolled
Updated 3 weeks ago
0
FairPhase 1Recruiting
RESTORE-HF: Cardiac Gene Therapy with BNP116 in Heart Failure
Heart FailureHeart Failure with Reduced Ejection Fraction
Tenaya Therapeutics|Stanford, CA
8/30 enrolled
Updated 2 weeks ago
0
FairPhase 1/2Recruiting
RESOLVE-RA: CAR-T Cell Therapy for Refractory Rheumatoid Arthritis
Rheumatoid Arthritis
Bristol-Myers Squibb|New York, NY
11/30 enrolled
Updated 2 weeks ago
0
LowPhase 3Recruiting
EVOLVE-MS: Tolebrutinib in Relapsing-Remitting Multiple Sclerosis
Multiple SclerosisRelapsing-Remitting MS
Sanofi|Los Angeles, CA
523/900 enrolled
Updated 2 weeks ago
0
LowPhase 3Recruiting
HOPE-SCD: CRISPR Gene Editing (Exa-cel) for Severe Sickle Cell Disease
Sickle Cell DiseaseSickle Cell Anemia
Vertex Pharmaceuticals / CRISPR Therapeutics|Philadelphia, PA
31/50 enrolled
Updated 3 weeks ago